Keyphrases
Subunit Vaccine
100%
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
100%
Middle East Respiratory Syndrome
100%
Receptor-binding Domain
100%
Domain-independent
100%
Immunogenicity
80%
MF59
80%
Neutralizing Antibodies
60%
T Cell Response
20%
Antibody Response
20%
Phosphoinositide Lipid
20%
Emerging Infectious Diseases
20%
High Titer
20%
Pandemic Potential
20%
Protein Receptor
20%
Commercially Available
20%
IgG1
20%
Spike Protein
20%
IgG Antibody Response
20%
Human IgG
20%
IgG2a
20%
Freund's Adjuvant
20%
Neutralization Antibody
20%
Antibody Protection
20%
Montanide
20%
Spread Potential
20%
Immunology and Microbiology
Adjuvant
100%
Subunit Vaccine
100%
Middle East Respiratory Syndrome Coronavirus
100%
Middle East Respiratory Syndrome
100%
Receptor Binding
100%
Immunogenicity
80%
Neutralizing Antibody
80%
MF59
80%
Antibody Response
40%
T Cell
20%
Phosphoryl Lipid A
20%
Titer
20%
Infectious Disease
20%
Spike
20%
Freund's Adjuvant
20%
Immunoglobulin G1
20%
Immunoglobulin G2a
20%
Montanide ISA 51
20%